Silver Spring News
-
Delcath Systems Inc. failed to win the backing of U.S. advisers for a chemotherapy drug-and-device combination because of the product’s high level of toxicity.
-
Aveo Pharmaceuticals Inc. failed to win the backing of U.S. regulatory advisers for its lead product candidate, a kidney cancer drug, after the panelists questioned whether it was as effective as existing treatments.
-
Washington is poised to be one of the only major U.S. cities with a decline in apartment rents this year after a surge in construction outpaced job growth, leaving the nation’s capital with a glut of properties.
-
BT Group Plc, BAE Systems Plc and Vodafone Group Plc are poised to submit final bids in a 12.1 billion-pound ($18.5 billion) U.K. program to install smart meters in every home.
-
GlaxoSmithKline Plc and Theravance Inc.’s Breo Ellipta should be approved to treat a lung disorder that is the third-leading cause of death in the U.S., advisers to the Food and Drug Administration said.
-
CBS Corp. Chief Executive Officer Leslie Moonves received $62.2 million in total compensation in 2012, a drop of 11 percent that still places him among the top- earning executives in the U.S.
-
GlaxoSmithKline Plc’s Avandia, the best-selling diabetes pill that was pulled off the market in Europe and tightly restricted in the U.S. because of its heart risks, will undergo another regulatory review.
-
Silver Spring Networks Inc., the maker of networking equipment for smart electricity grids, surged in its first day of trading after raising 21 percent more than planned in a U.S. initial public offering.
-
Silver Spring Networks Inc., the maker of networking equipment for smart electricity grids, seeks to raise about $67 million in its initial public offering, less than half the amount it initially sought, after waiting more than a year and a half to proceed with the sale.
-
Silver Spring Networks Inc., the maker of networking equipment for smart electricity grids, raised $81 million in its initial public offering after pricing an increased number of shares at the midpoint of the range.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page